Market Closed -
Bombay S.E.
06:00:50 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
180.3
INR
|
+0.78%
|
|
+0.81%
|
+10.31%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,469
|
6,004
|
3,358
|
6,885
|
9,654
|
5,124
|
Enterprise Value (EV)
1 |
5,232
|
5,796
|
3,206
|
6,702
|
9,502
|
5,075
|
P/E ratio
|
15.2
x
|
8.38
x
|
5.1
x
|
11
x
|
13.7
x
|
34.7
x
|
Yield
|
1.96%
|
2.19%
|
3.9%
|
2.22%
|
1.81%
|
0.85%
|
Capitalization / Revenue
|
1.2
x
|
1.3
x
|
0.81
x
|
1.71
x
|
1.61
x
|
1.02
x
|
EV / Revenue
|
1.4
x
|
1.25
x
|
0.78
x
|
1.67
x
|
1.58
x
|
1.01
x
|
EV / EBITDA
|
6.56
x
|
4.64
x
|
3.29
x
|
6.47
x
|
8.16
x
|
9.27
x
|
EV / FCF
|
-24.9
x
|
6.17
x
|
-13.9
x
|
68.4
x
|
-241
x
|
35.9
x
|
FCF Yield
|
-4.02%
|
16.2%
|
-7.19%
|
1.46%
|
-0.42%
|
2.79%
|
Price to Book
|
1.51
x
|
1.75
x
|
0.84
x
|
1.52
x
|
1.9
x
|
1.01
x
|
Nbr of stocks (in thousands)
|
31,851
|
43,736
|
43,644
|
43,644
|
43,644
|
43,644
|
Reference price
2 |
140.3
|
137.3
|
76.95
|
157.8
|
221.2
|
117.4
|
Announcement Date
|
7/21/18
|
8/5/19
|
8/7/20
|
7/7/21
|
7/6/22
|
8/18/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
3,733
|
4,624
|
4,137
|
4,020
|
6,013
|
5,015
|
EBITDA
1 |
797.9
|
1,250
|
975.8
|
1,035
|
1,165
|
547.5
|
EBIT
1 |
569.1
|
1,028
|
746.2
|
776.6
|
879.2
|
203.2
|
Operating Margin
|
15.24%
|
22.23%
|
18.04%
|
19.32%
|
14.62%
|
4.05%
|
Earnings before Tax (EBT)
1 |
624
|
1,042
|
785.5
|
810.7
|
952.8
|
203.7
|
Net income
1 |
403.4
|
715.1
|
658.1
|
626.6
|
705.8
|
147.5
|
Net margin
|
10.81%
|
15.46%
|
15.91%
|
15.59%
|
11.74%
|
2.94%
|
EPS
2 |
9.243
|
16.38
|
15.08
|
14.36
|
16.17
|
3.379
|
Free Cash Flow
1 |
-210.1
|
939.5
|
-230.7
|
98.02
|
-39.49
|
141.5
|
FCF margin
|
-5.63%
|
20.32%
|
-5.58%
|
2.44%
|
-0.66%
|
2.82%
|
FCF Conversion (EBITDA)
|
-
|
75.19%
|
-
|
9.47%
|
-
|
25.85%
|
FCF Conversion (Net income)
|
-
|
131.39%
|
-
|
15.64%
|
-
|
95.99%
|
Dividend per Share
2 |
2.750
|
3.000
|
3.000
|
3.500
|
4.000
|
1.000
|
Announcement Date
|
7/21/18
|
8/5/19
|
8/7/20
|
7/7/21
|
7/6/22
|
8/18/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
764
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
208
|
152
|
182
|
152
|
49.3
|
Leverage (Debt/EBITDA)
|
0.9572
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-210
|
940
|
-231
|
98
|
-39.5
|
142
|
ROE (net income / shareholders' equity)
|
14.4%
|
22.4%
|
17.7%
|
14.7%
|
14.7%
|
2.9%
|
ROA (Net income/ Total Assets)
|
6.98%
|
13.4%
|
9.39%
|
8.82%
|
9%
|
1.99%
|
Assets
1 |
5,783
|
5,355
|
7,009
|
7,108
|
7,840
|
7,416
|
Book Value Per Share
2 |
93.00
|
78.50
|
92.10
|
103.0
|
116.0
|
116.0
|
Cash Flow per Share
2 |
2.000
|
1.120
|
2.020
|
4.210
|
5.080
|
2.540
|
Capex
1 |
745
|
287
|
668
|
396
|
581
|
137
|
Capex / Sales
|
19.96%
|
6.21%
|
16.14%
|
9.86%
|
9.67%
|
2.73%
|
Announcement Date
|
7/21/18
|
8/5/19
|
8/7/20
|
7/7/21
|
7/6/22
|
8/18/23
|
|
1st Jan change
|
Capi.
|
---|
| +10.31% | 94.36M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|